Evidence map›Paper›PMID 37420490›Full record

ArticleEntropy (Basel, Switzerland)2022

Four-Objective Optimization of an Irreversible Magnetohydrodynamic Cycle.

Qingkun Wu, Lingen Chen, Yanlin Ge, Huijun Feng

Abstract read
In one paragraph

Article in Entropy (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qingkun WuInstitute of Thermal Science and Power Engineering, Wuhan Institute of Technology, Wuhan 430205, China.
Lingen ChenInstitute of Thermal Science and Power Engineering, Wuhan Institute of Technology, Wuhan 430205, China.ORCID 0000-0002-9012-6736
Yanlin GeInstitute of Thermal Science and Power Engineering, Wuhan Institute of Technology, Wuhan 430205, China.
Huijun FengInstitute of Thermal Science and Power Engineering, Wuhan Institute of Technology, Wuhan 430205, China.

Funding

National Natural Science Foundation of China 52171317
6 · The paper itself

Abstract

Based on the existing model of an irreversible magnetohydrodynamic cycle, this paper uses finite time thermodynamic theory and multi-objective genetic algorithm (NSGA-II), introduces heat exchanger thermal conductance distribution and isentropic temperature ratio of working fluid as optimization variables, and takes power output, efficiency, ecological function, and power density as objective functions to carry out multi-objective optimization with different objective function combinations, and contrast optimization results with three decision-making approaches of LINMAP, TOPSIS, and Shannon Entropy. The results indicate that in the condition of constant gas velocity, deviation indexes are 0.1764 acquired by LINMAP and TOPSIS approaches when four-objective optimization is performed, which is less than that (0.1940) of the Shannon Entropy approach and those (0.3560, 0.7693, 0.2599, 0.1940) for four single-objective optimizations of maximum power output, efficiency, ecological function, and power density, respectively. In the condition of constant Mach number, deviation indexes are 0.1767 acquired by LINMAP and TOPSIS when four-objective optimization is performed, which is less than that (0.1950) of the Shannon Entropy approach and those (0.3600, 0.7630, 0.2637, 0.1949) for four single-objective optimizations, respectively. This indicates that the multi-objective optimization result is preferable to any single-objective optimization result.

Indexed as

deviation indexfinite time thermodynamicsirreversible MHD cyclemulti-objective optimizationNSGA-II algorithmperformance comparison

Identifiers

PMID37420490
PMCPMC9601762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.